Insiders · Profile

Ege David S.

See Remarks at Seres Therapeutics. Filing since 31 Oct 2022. CIK 0001829360

Company
Date
Role
Action
Shares
Amount
Of holding
16 Aug 2024
See Remarks
Sold on a plan
1,128
$947.52
1.4%
15 May 2024
See Remarks
Sold on a plan
1,090
$1.02K
1.4%
16 Feb 2024
See Remarks
Sold on a plan
5,010
$5.41K
6.4%
30 Oct 2023
See Remarks
Sold on a plan
4,066
$5.49K
5.7%
28 Apr 2023
See Remarks
Sold at will
7,038
$36.53K
10.5%
31 Oct 2022
See Remarks
Sold, plan not stated
5,012
$39.75K
9.7%
6 decisions on file.